Chavda, V.P.; Ajabiya, J.; Teli, D.; Bojarska, J.; Apostolopoulos, V.
Correction: Chavda et al. Tirzepatide, a New Era of Dual-Targeted Treatment for Diabetes and Obesity: A Mini-Review. Molecules 2022, 27, 4315. Molecules 2025, 30, 1190.
https://doi.org/10.3390/molecules30061190
AMA Style
Chavda VP, Ajabiya J, Teli D, Bojarska J, Apostolopoulos V.
Correction: Chavda et al. Tirzepatide, a New Era of Dual-Targeted Treatment for Diabetes and Obesity: A Mini-Review. Molecules 2022, 27, 4315. Molecules. 2025; 30(6):1190.
https://doi.org/10.3390/molecules30061190
Chicago/Turabian Style
Chavda, Vivek P., Jinal Ajabiya, Divya Teli, Joanna Bojarska, and Vasso Apostolopoulos.
2025. "Correction: Chavda et al. Tirzepatide, a New Era of Dual-Targeted Treatment for Diabetes and Obesity: A Mini-Review. Molecules 2022, 27, 4315" Molecules 30, no. 6: 1190.
https://doi.org/10.3390/molecules30061190
APA Style
Chavda, V. P., Ajabiya, J., Teli, D., Bojarska, J., & Apostolopoulos, V.
(2025). Correction: Chavda et al. Tirzepatide, a New Era of Dual-Targeted Treatment for Diabetes and Obesity: A Mini-Review. Molecules 2022, 27, 4315. Molecules, 30(6), 1190.
https://doi.org/10.3390/molecules30061190